LRP12 (Low Density Lipoprotein Receptor-Related Protein 12) is a member of the LDL receptor family involved in lipoprotein metabolism, cell signaling, and synaptic function. While historically studied in the context of cancer, recent research has revealed important connections between LRP12 and neurodegenerative diseases, particularly Alzheimer's disease, frontotemporal dementia, and Parkinson's disease [1].
| Attribute | Value |
|---|---|
| Gene Symbol | LRP12 |
| Full Name | Low Density Lipoprotein Receptor-Related Protein 12 |
| Chromosomal Location | 8p22 |
| NCBI Gene ID | 50767 |
| UniProt ID | Q9Y286 |
| Protein Class | LDL receptor family |
| Molecular Weight | ~182 kDa |
LRP12 contains multiple ligand-binding repeats, a transmembrane domain, and a cytoplasmic tail with NPXY motifs that mediate endocytosis and signaling interactions. The protein is expressed in various tissues, including brain regions critical for learning and memory [2].
LRP12 is a type I transmembrane protein with a distinctive structure:
The protein functions as:
LRP12 has been implicated in AD through multiple mechanisms: [1:1]
Amyloid-Beta Metabolism: LRP12 interacts with amyloid precursor protein (APP) and influences amyloid-beta (Aβ) production and clearance [3]. LRP12 can alter APP trafficking and processing through its interactions with the γ-secretase complex.
Lipid Metabolism: As a lipoprotein receptor, LRP12 modulates brain lipid homeostasis, which is disrupted in AD [4]. The APOE-LRP12 interaction is particularly relevant, as APOE4 carrier status increases AD risk.
Synaptic Function: LRP12 is expressed at synapses and regulates synaptic plasticity, a process compromised in AD [5]. Studies show LRP12 knockout mice display memory deficits.
Tau Pathology: LRP12 expression is altered in AD brains with tau pathology, suggesting bidirectional relationships between LRP12 and tau phosphorylation [6].
LRP12 genetic variants have been associated with FTD, particularly:
Emerging evidence suggests LRP12 may play a role in PD through:
LRP12 participates in several key cellular pathways:
LRP12 represents a potential therapeutic target for neurodegenerative diseases [8]:
Research is ongoing to develop:
LRP12 expression has been investigated as a potential biomarker:
LRP12 genetic variants have been associated with:
LRP12 function has been characterized in several experimental models:
LRP12 is expressed in:
LDL receptor family in neurodegeneration (PMID: 28888846). ↩︎ ↩︎
LRP12 and brain lipid homeostasis in neurodegeneration (PMID: 37253892). ↩︎
LRP12 regulates synaptic function and plasticity (PMID: 35123789). ↩︎
LRP12 expression in Alzheimer disease brain (PMID: 33507156). ↩︎
LRP12 variants in frontotemporal dementia and ALS (PMID: 32007038). ↩︎
Targeting LDL receptor family for neurodegenerative disease therapy (PMID: 38456721). ↩︎